Crinetics Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Crinetics Pharmaceuticals, Inc. (CRNX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.260.050.330.330.170.120.16
Short-Term Investments1.090.500.300.130.080.000.00
Cash & Short-Term Investments1.350.560.330.330.170.120.16
Accounts Receivable0.010.010.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.000.000.000.000.000.00
Total Current Assets1.380.570.350.340.180.120.17
Non-Current Assets
Property, Plant & Equipment (Net)0.060.060.000.000.010.010.00
Long-Term Investments0.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.060.060.010.010.010.010.00
Total Assets1.430.640.350.350.180.130.17
Current Liabilities
Accounts Payable0.010.010.020.010.010.010.01
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.020.030.020.010.010.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.000.000.010.000.000.000.00
Total Current Liabilities0.060.040.030.020.010.010.01
Non-Current Liabilities
Long-Term Debt0.040.050.000.000.000.000.00
Other Non-Current Liabilities0.000.010.000.010.000.000.00
Total Non-Current Liabilities0.050.050.010.010.010.010.00
Total Liabilities0.110.100.040.020.010.010.01
Stockholders' Equity
Common Stock2.281.190.760.610.340.000.00
Retained Earnings-0.95-0.65-0.44-0.28-0.17-0.09-0.04
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital0.000.000.000.000.000.000.20
Shares Outstanding0.090.070.050.050.000.000.00
Total Stockholders' Equity1.320.540.320.330.170.120.16
Total Liabilities & Equity1.430.640.350.350.180.130.17